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Background
Fc gamma receptor IIIA (CD16/FCgRIIIA) on mono-
cytes/macro-phages may play an important role in the
pathogenesis of severe malarial anemia (SMA) by pro-
moting phagocytosis of IgG-coated uninfected red cells
and by allowing the production of tumor necrosis fac-
tor alpha (TNF-a) upon cross-linking by immune com-
plexes (ICs). However, not much is known about the
differential expression of this receptor on monocytes
of children with severe malaria and uncomplicated
malaria.
Materials and methods
We investigated the expression of CD16/FCgRIIIA on
monocytes of children with SMA, cerebral malaria
(CM), and their age-matched uncomplicated malaria
controls by flow cytometry. Since CD14low (CD14+)
monocytes are considered more mature and macro-
phage-like than CD14high (CD14++) monocytes, we
also compared the level of expression of CD16/FCgRIIIA
according to the CD14 level and studied the relationship
between CD16/FCgRIIIA expression and intracellular
TNF- production upon stimulation by ICs.
Results
CD16/FcgRIIIA expression was the highest overall on
CD14+CD16+ monocytes of children with SMA at
enrollment. At convalescence, SMA children were the
only ones to show a significant decline in the same
parameter. In contrast, there were no significant differ-
ences among groups in the expression of CD16/
FCgRIIIA on CD14++CD16+ monocytes. A greater per-
centage of CD14+CD16+ monocytes produced TNF-a
upon stimulation than any other monocyte subset, and
the amount of intracellular TNF-a correlated positively
with CD16/FcRIIIA expression. Furthermore, there was
an inverse correlation between hemoglobin levels and
CD16/FCgRIIIA expression in children with SMA and
their controls.
Conclusions
These data suggest that monocytes of children with
SMA respond differently to Plasmodium falciparum
infection by overexpressing CD16/FCgRIIIA as they
mature, which could enhance erythrophagocytosis and
TNF production.
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